title: Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia.
authors.forename: Cristina
authors.initials: C
authors.lastname: Tecchio
authors.forename: Ilaria
authors.initials: I
authors.lastname: Nichele
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Todeschini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Pizzolo
authors.forename: Achille
authors.initials: A
authors.lastname: Ambrosetti
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib